{
    "clinical_study": {
        "@rank": "13255", 
        "arm_group": [
            {
                "arm_group_label": "Low energy laser", 
                "arm_group_type": "Experimental", 
                "description": "Administration of a low energy laser for oral mucositis."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effectiveness of using to low intensity laser\n      as an intervention against preventive and therapeutic oral mucositis induced by radiotherapy\n      and chemotherapy."
        }, 
        "brief_title": "Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer", 
        "condition": "Oral Mucositis", 
        "condition_browse": {
            "mesh_term": [
                "Head and Neck Neoplasms", 
                "Stomatitis", 
                "Mucositis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients diagnosed with squamous cell carcinoma of the oral cavity.\n\n          -  Patients aged between 18 and 80 years.\n\n          -  Patients who are to receive one of the following treatment\n\n          -  Combined radiotherapy (conventional fractionation 70 Gy reaching  the tumor and\n             affected lymph nodes, and 50 Gy in the areas ganglion drainage) and chemotherapy\n             (cisplatin 100 mg/m2 IV on days 1, 22 and 43 irradiation or cetuximab 400mg/m2 as a\n             single dose pre-load radiotherapy and 250mg/m2 weekly for the same. Regardless of\n             whether they have received previous surgical treatment.\n\n          -  Treatment with radiotherapy of 70 Gy in 35 daily sessions 2Gy/d\u00eda consecutive.\n\n          -  Patients who voluntarily express their intention to participate by informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients who denied informed consent.\n\n          -  Patients who have hypersensitivity or allergy to any of the components included in\n             the study.\n\n          -  Patients diagnosed with HIV, and autoimmune diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "126", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01876407", 
            "org_study_id": "FPS-LAS-2012-04", 
            "secondary_id": "001001006001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low energy laser", 
                "intervention_name": "Low intensity laser for oral mucositis", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Low intensity laser for oral mucositis switch off", 
                "intervention_name": "Low intensity laser for oral mucositis switch off", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "contact": {
                "email": "danieltl@us.es", 
                "last_name": "Daniel Torres Lagares"
            }, 
            "facility": {
                "address": {
                    "city": "Sevilla", 
                    "country": "Spain", 
                    "zip": "41013"
                }, 
                "name": "Hospital Universitario Virgen del Roc\u00edo"
            }, 
            "investigator": {
                "last_name": "Daniel Torres Lagares", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "danieltl@us.es", 
            "last_name": "Daniel Torres Lagares"
        }, 
        "overall_contact_backup": {
            "email": "gestionensayosclinicos.fps@juntadeandalucia.es", 
            "last_name": "Mar\u00eda del Mar Benjumea Vargas", 
            "phone": "955 04 04 50"
        }, 
        "overall_official": {
            "affiliation": "Hospitales Universitarios Virgen del Roc\u00edo", 
            "last_name": "Daniel Torres Lagares", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Evaluate the effectiveness of using low-intensity laser compared with placebo as preventive and therapeutic intervention of oral mucositis induced by radiation therapy and chemotherapy.", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01876407"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Evaluate the effectiveness of using low level laser compared with placebo in the prevention of onset of oral mucositis induced by treatment of head and neck QRT.", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Evaluate the effectiveness of the use of low laser intensity versus placebo in improving the healing of oral mucositis induced by treatment of head and neck QRT.", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Evaluate the effectiveness of using low level laser compared with placebo in reducing pain during and after cancer treatment.", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Evaluate the effectiveness of using low level laser compared with placebo in analgesic use during and after cancer treatment.", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Assess the intervention tolerance and side effects of it.", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }
        ], 
        "source": "Fundaci\u00f3n P\u00fablica Andaluza Progreso y Salud", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3n P\u00fablica Andaluza Progreso y Salud", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}